Results 131 to 140 of about 56,993 (185)

The effect of sevelamer on serum calcification propensity in patients with chronic kidney disease: the results of a multicentre, double-blind, placebo-controlled, randomized clinical trial. [PDF]

Clin Kidney J
Pluquet M, Laville SM, Brazier F, Ureña-Torres P, El Esper N, Kamel S, Choukroun G, Liabeuf S.   +7 more
europepmc   +1 more source

Phosphate binder in dialysis: a cross-sectional study of patients' adherence and pill burden. [PDF]

J Bras Nefrol
Ferezin BBSC, Araújo LKRP, Lima CM, Abensur H, Pereira BJ, Dalboni MA, Moyses RMA, Elias RM.   +7 more
europepmc   +1 more source

A Large Deletion With a Large Impact: Homozygous 5,600 bp Deletion of the <i>GALNT3</i> Gene Causing Hyperphosphatemic Tumoral Calcinosis. [PDF]

Kidney Med
Portmann JM, Martini K, Bahr A, Ritter A, Wagner CA, Seeger H.   +5 more
europepmc   +1 more source

Histopathological lesions of the gastrointestinal tract associated with the use of polystyrene sulfonate and sevelamer: a meta-analysis. [PDF]

Pathologica
Di Rienzo G, Crafa P, Delsante M, Fiaccadori E, Pedrazzi G, Campanini N, Corradini E.   +6 more
europepmc   +1 more source

Association of Sevelamer Initiation with Gastrointestinal Bleeding Hospitalization in Individuals Requiring Hemodialysis. [PDF]

Am J Nephrol
Le D, Crews DC, Grams ME, Coresh J, Shin JI.   +4 more
europepmc   +1 more source

A Pan-Inhibitor of Phosphate Transporters AP306 in Hemodialysis Patients. [PDF]

Kidney Int Rep
Wang L, Zuo L, Shi M, Gu L, Ma K, Wang P, Wang Y, Luo Q, Chen M, Zhang P, Jiang H, Li G, Zhang W, Liu YC, Zhao Q.   +14 more
europepmc   +1 more source

Exploring the top 30 drugs associated with drug-induced constipation based on the FDA adverse event reporting system. [PDF]

Front Pharmacol
Li W, Liu C, Zhang Z, Cai Z, Lv T, Zhang R, Zuo Y, Chen S.   +7 more
europepmc   +1 more source

Multiple Ectopic calcifications in end-stage renal disease: role of inflammation and partial reversibility with intensified peritoneal dialysis-a case report. [PDF]

BMC Nephrol
Hu S, Zhang Z, Sun D, Chen Y, Wang N, Xu T.   +5 more
europepmc   +1 more source

Sucroferric oxyhydroxide monotherapy for hyperphosphatemia in Indian chronic kidney disease patients undergoing hemodialysis: A phase IV, single-arm, open-label study. [PDF]

World J Nephrol
Niranjan MR, Srinivasa S, Gupta V, Bhalla AK, Gaikwad A, Wangikar P, Suryawanshi S, Gajbe P.   +7 more
europepmc   +1 more source